NCT00363402View on ClinicalTrials.gov

18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

December 31, 2007

Conditions
Cystic Fibrosis
Interventions
PROCEDURE

PET-CT

Trial Locations (1)

24035

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00363402 - 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF) | Biotech Hunter | Biotech Hunter